Addex Therapeutics (ADXN) Payables (2022 - 2025)
Historic Payables for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to $1.5 million.
- Addex Therapeutics' Payables rose 4361.0% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 4361.0%. This contributed to the annual value of $903435.7 for FY2024, which is 6597.02% down from last year.
- Per Addex Therapeutics' latest filing, its Payables stood at $1.5 million for Q3 2025, which was up 4361.0% from $1.4 million recorded in Q2 2025.
- Addex Therapeutics' 5-year Payables high stood at $4.2 million for Q2 2022, and its period low was $907266.7 during Q4 2024.
- In the last 4 years, Addex Therapeutics' Payables had a median value of $2.7 million in 2023 and averaged $2.4 million.
- The largest annual percentage gain for Addex Therapeutics' Payables in the last 5 years was 4361.0% (2025), contrasted with its biggest fall of 7222.5% (2025).
- Quarter analysis of 4 years shows Addex Therapeutics' Payables stood at $3.1 million in 2022, then decreased by 13.57% to $2.7 million in 2023, then plummeted by 66.25% to $907266.7 in 2024, then skyrocketed by 60.84% to $1.5 million in 2025.
- Its Payables was $1.5 million in Q3 2025, compared to $1.4 million in Q2 2025 and $1.1 million in Q1 2025.